| Issue Date | Title | Author(s) |
| 2015 | The 5-HT4 agonist prucalopride stimulates L-DOPA-induced dopamine release in restricted brain regions of the hemiparkinsonian rat in vivo | Navailles, Sylvia; Di Giovanni, Giuseppe; De Deurwaerdere, Philippe |
| 2017 | Expanding the repertoire of L-DOPA’s actions : a comprehensive review of its functional neurochemistry | De Deurwaerdere, Philippe; Di Giovanni, Giuseppe; Millan, Mark J. |
| 2014 | Meeting report : Neuropathology and Neuropharmacology of Monoaminergic systems | Ramsay, Rona R.; De Deurwaerdere, Philippe |
| 2016 | Monoaminergic and histaminergic strategies and treatments in brain diseases | Di Giovanni, Giuseppe; Svob Strac, Dubravka; Sole, Montse; Unzeta, Mercedes; Tipton, Keith F.; Muck-Seler, Dorotea; Bolea, Irene; Della Corte, Laura; Nikolac Perkovic, Matea; Pivac, Nela; Smolders, Ilse J.; Stasiak, Anna; Fogel, Wieslawa A.; De Deurwaerdere, Philippe |
| 2016 | Monoaminergic mechanisms in epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugs | Svob Strac, Dubravka; Pivac, Nela; Smolders, Ilse J.; Fogel, Wieslawa A.; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe |
| 2014 | N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA) : a potential cognitive enhancer with MAO inhibitor properties | Di Giovanni, Giuseppe; Garcia, Isela; Colangeli, Roberto; Pierucci, Massimo; Rivadulla, Marcos L.; Soriano, Elena; Chioua, Mourand; Della Corte, Laura; Yanez, Matilde; De Deurwaerdere, Philippe; Fall, Yagamare; Marco-Contelles, Jose |
| 2017 | Neurobiology and neuropharmacology of monoaminergic systems | De Deurwaerdere, Philippe; Ramsay, Rona R.; Di Giovanni, Giuseppe |
| 2016 | New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disorders | Di Giovanni, Giuseppe; De Deurwaerdere, Philippe |
| 2014 | Noradrenergic terminals regulate l-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian rats | Navailles, Sylvia; Milan, Lea; Khalki, Hanane; Di Giovanni, Giuseppe; Lagiere, Melanie; De Deurwaerdere, Philippe |
| 2014 | Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease | Navailles, Sylvia; Di Giovanni, Giuseppe; De Deurwaerdere, Philippe |
| 2014 | Role of central serotonin receptors in nicotine addiction | Pierucci, Massimo; Chambers, Stephanie; Partridge, Lucy; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe |
| 2014 | Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized rats | Orban, Gergely; Bombardi, Cristiano; Marino Gammazza, Antonella; Colangeli, Roberto; Pierucci, Massimo; Pomara, Cristoforo; Pessia, Mauro; Bucchieri, Fabio; Arcangelo, Benigno; Smolders, Ilse J.; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe |
| 2015 | Serotonergic modulation of the activity of mesencephalic dopaminergic systems : therapeutic implications | De Deurwaerdere, Philippe; Di Giovanni, Giuseppe |
| 2017 | TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7- yl]methanamine] : a hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above? | Di Giovanni, Giuseppe; De Deurwaerdere, Philippe |
| 2016 | Updating neuropathology and neuropharmacology of monoaminergic systems | Ramsay, Rona R.; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe |
